Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-04-03
2007-04-03
Page, Thurman K. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S079000
Reexamination Certificate
active
11005871
ABSTRACT:
The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treatment or prophylaxis of undesired thrombosis.
REFERENCES:
patent: 4379146 (1983-04-01), Greenlee et al.
patent: 5006515 (1991-04-01), Schwab et al.
patent: 5403829 (1995-04-01), Lehtinen et al.
patent: 5728650 (1998-03-01), Fisher et al.
patent: 5854227 (1998-12-01), Hartmann et al.
patent: 6096730 (2000-08-01), Collins et al.
patent: 6160166 (2000-12-01), Collins et al.
patent: 6828312 (2004-12-01), Jiao et al.
patent: 3203307 (1983-07-01), None
patent: 19738005 (1999-03-01), None
patent: 623625 (1994-11-01), None
patent: WO 91/05791 (1991-05-01), None
patent: WO 94/07501 (1994-04-01), None
patent: WO 96/31124 (1996-10-01), None
patent: WO 97/09063 (1997-03-01), None
patent: WO 98/40408 (1998-09-01), None
patent: WO 99/03498 (1999-01-01), None
patent: WO 00/018398 (2000-04-01), None
patent: WO 00/077246 (2000-12-01), None
patent: WO 03/061567 (2003-07-01), None
E.R.van Beek, C.W.G.M. Lowik, F.H.Ebetino, and S.E. Papapoulos Binding and Antiresorptive Properties of Heterocycle-Containing Bisphosphonate Analogs: Structure-Activity Relationships Bone vol. 23, No. 5, 1998, 437-442.
CA:99:212705 abs of DE 3203307, Jul. 28, 1983.
CA:119:28231 abs of Bioorg. Med. Chem. Lett. by Fletcher et al. 3(2) pp. 141-146, 1993.
CA:107:59121 abs of J. Med. Chem. by Nguyen et al. 30(8) pp. 1426-1433, 1987.
CA:120:219245 abs of Macromolecules by Chan 27(8) pp. 2159-2164, 1994.
CA:121:179868 abs of WO 9407501, Apr. 14, 1994.
CA:124:45717 abs of JP07242538, Sep. 1995.
CA:125:212249 abs of Blood Coagulation Fibrinolysis by Harenberg et al. 7(4) pp. 477-463, 1996.
CA:125:320562 abs of WO 9631124, Apr. 1996.
CA:126:324966 abs of Res. Virol. by Grimaldi et al. 148(2) pp. 177-180, 1997.
CA:127:5356 abs of WO 9715598, May 1997.
CA:130:209820 abs of DE 19738005, Mar. 1999.
CA:134:37031 abs of WO 2000077246, Dec. 2000.
CA:139:149413 abs of WO 2003061567, Jul. 2003.
CA:123:33653 abs of EP 623625, Nov. 9, 1994.
Chemical Abstracts, vol. 93, No. 25, Abstract No. 239522 (1980).
Chan et al., “Polyanilines Doped with Phosphonic Acids: Their Preparation and Characterization.”Macromolecules.27: 2159-2164 (1994).
Fletcher et al. “4-Hydroxyphenoxymethylene Bisphosphonic Acid Derivatives: Potent, Non-hydrolysable Inhibitors of myo-Inositol Monophosphatase.”Bioorganic&Medicinal Chemistry Letters.3(2): 141-146 (1993).
Grimaldi et al. “Attempts to Use Liposomes and RBC Ghosts as Vectors in Drug and Antisense Therapy of Virus Infection.”Res. Virol.148: 177-180 (1997).
Ksander et al., “Dual Antiotensin Converting Enzyme/Thromboxane Synthase Inhibitors.”Journal of Medicinal Chem.37:1823-1832 (1994).
Nguyen et al., “gem-Diphosphonate and gem-Phosphonate-phosphate Compounds with Specific High Density Lipoprotein Inducing Activity.”J. Med. Chem.30: 1426-33 (1987).
Jiao Jin-An
Luepschen Lawrence K.
Nieves Esperanza
Taylor Dean P.
Wong Hing C.
Foley & Hoag LLP
Nagubandi Lalitha
Page Thurman K.
LandOfFree
Pharmaceutically active compounds and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically active compounds and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active compounds and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773214